Şunu aradınız:: mavesårsmedicin (Danca - İngilizce)

mavesÅrsmedicin
these results indicate that raltegravir is not an inducer or inhibitor of cyp3a4, and raltegravir is thus not anticipated to affect the pharmacokinetics of medicinal products which are cyp3a4 substrates.

mavesÅrsmedicin omeprazol (raltegravir 400 mg sd)
antiulcer omeprazole (raltegravir 400 mg sd)

hvis gastrointestinal blødning opstår behandles dette med mavesårsmedicin.
if gastrointestinal bleeding is suspected, administer gastric protectants.

samtidig administration afprotonpumpehæmmere elleranden mavesårsmedicin kan øge raltegravirs plasma -koncentrationer.
co-administration of proton pump inhibitors or other antiulcer medicinal products may increase plasma levels of raltegravir.

samtidig administration af protonpumpehæmmere eller anden mavesårsmedicin kan øge raltegravirs plasma - koncentrationer.
co-administration of proton pump inhibitors or other antiulcer medicinal products may increase plasma levels of raltegravir.

nedsætter immunforsvaret (som undertiden gives til patienter efter en transplantationsoperation), colestyramin (som bruges til behandling af patienter med for højt kolesteroltal), rifampicin (antibiotika), mavesårsmedicin, phosphatbindere (bruges til patienter med kronisk nyresvigt for at reducere absorptionen af phosphat) eller anden medicin (inklusive håndkøbsmedicin), som din læge ikke er bekendt med?
are sometimes given to patients after a transplant operation), cholestyramine (used to treat patients 39 with high blood cholesterol), rifampicin (antibiotic), antacids, phosphate binders (used in patients with chronic renal kidney failure to reduce the absorption of phosphate) or any other medicines (including those you can buy without a prescription) that your doctor does not know about?